Skip to Main Content

Author Details

Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
2008
38
22
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
37528411Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes.Genome Biol2023
37540673Two opposing gene expression patterns within ATRX aberrant neuroblastoma.PLoS One2023
34963094Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.Eur J Cancer2022
36182817Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.Eur J Cancer2022
36237330Chromosome 11q loss and <i>MYCN</i> amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.Front Oncol2022
34117376BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer.Cell Death Differ2021
33547074Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.Sci Adv2021
33673003AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.Cancers (Basel)2021
34408135Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.Nat Commun2021
34433038Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors.Cell Rep2021
34575700αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression.J Pers Med2021
31526760Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.Cancer Cell2019
30151914Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.Int J Cancer2019
29305587Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Cell Death Differ2018
28692036Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.Oncogenesis2017
28368388Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer.Oncogenesis2017
26733613A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.Clin Cancer Res2016
27221051TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.EMBO Mol Med2016
27157610A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.Oncogene2016
26797113An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF.Sci Rep2016
24764155Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.Head Neck2015
26700642A high-resolution gene expression atlas of epistasis between gene-specific transcription factors exposes potential mechanisms for genetic interactions.BMC Biol2015
26160848ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).Oncotarget2015
26022646The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.Pathobiology2015
24766815Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors.Cell2014
23441134PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.Neoplasia2013
24002600Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.Br J Cancer2013
21976730Tight cooperation between Mot1p and NC2β in regulating genome-wide transcription, repression of transcription following heat shock induction and genetic interaction with SAGA.Nucleic Acids Res2012
23185333Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases.PLoS One2012
23182196Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma.Lancet Oncol2012
23028359Two distinct repressive mechanisms for histone 3 lysine 4 methylation through promoting 3'-end antisense transcription.PLoS Genet2012
23045589Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.J Clin Oncol2012
21596317The specificity and topology of chromatin interaction pathways in yeast.Mol Cell2011
21145464Functional overlap and regulatory links shape genetic interactions between signaling pathways.Cell2010
19320556The construction of genome-based transcriptional units.OMICS2009
19401678Adaptable gene-specific dye bias correction for two-channel DNA microarrays.Mol Syst Biol2009
18689827Organization and integration of biomedical knowledge with concept maps for key peroxisomal pathways.Bioinformatics2008
  • 1 - 38 of 38

Recommended Authors

Moores Cancer Center, University of California
Career Start Year 2015
Number of shared co-authors 0
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 2
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 6
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Washington University
Career Start Year 2003
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 0
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 2
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 15
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 4
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 6
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 4
University of California San Diego
Career Start Year 1988
Number of shared co-authors 4

Collaborators

Princess Maxima Center for Pediatric Oncology
Co-authored papers 15
Oncode Institute
Co-authored papers 11
Co-authored papers 9
Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University
Co-authored papers 8
Princess Maxima Center for Pediatric Oncology Research
Co-authored papers 7
Princess Maxima Center for Pediatric Oncology
Co-authored papers 6
Princess Maxima Center for Pediatric Oncology
Co-authored papers 6
Princess Maxima Center for Pediatric Oncology
Co-authored papers 6
Princess Maxima Center for Pediatric Oncology
Co-authored papers 5
Amsterdam University Medical Centers location AMC
Co-authored papers 5
Oncode Institute
Co-authored papers 5
Center for Molecular Medicine, University Medical Center Utrecht
Co-authored papers 5
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 5
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 4
the Netherlands Cancer Institute, Oncode Institute
Co-authored papers 4
Center for Molecular and Cellular Bioengineering
Co-authored papers 4
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 4
University Medical Center Utrecht
Co-authored papers 3
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 3
Utrecht University
Co-authored papers 3
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 3
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Vrije Universiteit Amsterdam
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 2
Wageningen University and Research
Co-authored papers 2
Princess Maxima Center for Pediatric Oncology
Co-authored papers 2
Leibniz Forschungsinstitut fur Molekulare Pharmakologie (FMP)
Co-authored papers 1
Co-authored papers 1